Clinical Trial Update: Dietary Protein in the Very-low-birth-weight Infant [NA]

View source ↗

Summary

The Nestlé-sponsored clinical trial evaluating dietary protein in very-low-birth-weight infants has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prematurity

Snippet

Sponsor: Société des Produits Nestlé (SPN) | Conditions: Prematurity | NA | Status: TERMINATED